Kimberly-Clark de México, S. A. B. de C. V. (KCDMY) Q4 2023 Earnings Call Transcript
https://seekingalpha.com/article/4663817-kimberly-clark-de-mexico-s-b-de-c-v-kcdmy-q4-2023-earnings-call-transcript?source=feed_sector_transcripts
Jan 19, 2024 - Kimberly-Clark de México, S. A.
0
S&P 500 Jumps To New Record Intraday High
https://www.rttnews.com/story.aspx?Id=3417904
Jan 19, 2024 - After moving moderately higher early in the session, stocks have seen further upside over the course of the trading day on Friday. The major averages are extending the upward move seen on Thursday, with the S&P 500 reaching a new record intraday high.
0
Genmab A/S Sponsored ADR (GMAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
https://www.zacks.com/stock/news/2212832/genmab-a-s-sponsored-adr-gmab-may-find-a-bottom-soon-here-s-why-you-should-buy-the-stock-now?cid=CS-ZC-FT-tale_of_the_tape|hammer_chart_pattern_(ta)-2212832
Jan 19, 2024 - After losing some value lately, a hammer chart pattern has been formed for Genmab A/S Sponsored ADR (GMAB), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
0
Caribou Coffee enters long-term strategic CPG license agreement with JDE Peet's
https://www.nrn.com/fast-casual/caribou-coffee-enters-long-term-strategic-cpg-license-agreement-jde-peets
Jan 18, 2024 - Transaction will enable Caribou Coffee to build on its core strategy of operating and growing its retail coffeehouse business while recognizing successful development of its consumer packaged goods business
0
The weight loss drug market may soon get more crowded. Here are the companies trying to enter the booming space
https://www.cnbc.com/2024/01/17/weight-loss-drugs-boehringer-ingelheim-terns-viking-may-join-market.html
Jan 18, 2024 - Wall Street has been focused on Novo Nordisk, Eli Lilly and other large drugmakers hoping to join the weight loss drug market, such as Pfizer, Roche and Amgen.
0
U.S. Stocks Move Mostly Lower As Data Adds To Interest Rate Uncertainty
https://www.rttnews.com/story.aspx?Id=3417323
Jan 17, 2024 - After coming under pressure early in the session, stocks remained mostly lower throughout the trading day on Wednesday. The major averages added to the losses posted during Tuesday's session, with the Dow falling to its lowest closing level in almost a month.
0
U.S. Stocks May See Further Downside In Early Trading
https://www.rttnews.com/story.aspx?Id=3417257
Jan 17, 2024 - After ending the previous session mostly lower, stocks may see further downside in early trading on Wednesday. Ongoing uncertainty about the outlook for interest rates may weigh on Wall Street amid recent concerns the Federal Reserve won't lower rates as early as previously anticipated.
0
These Stocks Are Showing Relative Strength as S&P 500 Stalls Near Record High
https://www.zacks.com/commentary/2211005/these-stocks-are-showing-relative-strength-as-s-p-500-stalls-near-record-high?cid=CS-ZC-FT-investment_ideas-2211005
Jan 16, 2024 - As investors, our job isn't to predict an unknowable future.
0
4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry
https://www.cnbc.com/2024/01/15/jim-cramer-4-health-stock-ideas-from-jpmorgan-health-care-conference.html
Jan 15, 2024 - Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech.
0
MediWound (MDWD)'s Technical Outlook is Bright After Key Golden Cross
https://www.zacks.com/stock/news/2210222/mediwound-mdwd-s-technical-outlook-is-bright-after-key-golden-cross?cid=CS-ZC-FT-tale_of_the_tape|golden_crossover-2210222
Jan 15, 2024 - Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
0